Norfloxacino Stada

Norfloxacin, the active ingredient in Norfloxacino Stada, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats a range of bacterial infections in adults and children when prescribed by a qualified health professional.

GNH USA supplies Norfloxacino Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norfloxacino Stada is a fluoroquinolone antibiotic indicated for several bacterial infection categories.

- Uncomplicated urinary tract infection: eradicates susceptible Gram‑negative pathogens and relieves dysuria and frequency. - Acute bacterial prostatitis: penetrates prostatic tissue to eliminate causative organisms. - Traveler’s diarrhea (enteric infections): reduces duration and severity of gastrointestinal symptoms caused by susceptible bacteria. - Gonococcal urethritis: provides effective bactericidal activity against Neisseria gonorrhoeae. - Acute exacerbations of chronic bronchitis: helps control bacterial load in the lower respiratory tract.

Norfloxacino Stada may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema or itching. - Photosensitivity: increased sunburn risk.

Serious or Rare Side Effects: - Tendon rupture or tendinitis, especially in the Achilles tendon. - QT interval prolongation leading to cardiac arrhythmias. - Severe allergic reactions such as Stevens‑Johnson syndrome. - Clostridioides difficile‑associated colitis. - Hepatic dysfunction with elevated transaminases. - Peripheral neuropathy presenting as tingling or numbness.

Before prescribing Norfloxacino Stada, clinicians should consider several safety factors.

- Renal impairment: assess kidney function and adjust dosing if necessary. - History of tendon disorders: avoid use in patients with prior tendon injury. - Concomitant QT‑prolonging agents: monitor cardiac rhythm closely. - Pregnancy: reserve for situations where benefits outweigh potential fetal risk. - Known hypersensitivity to fluoroquinolones: contraindicated. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Norfloxacino Stada can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce norfloxacin absorption. - Warfarin: may potentiate anticoagulant effect, increasing bleeding risk. - Theophylline: can raise serum theophylline concentrations, leading to toxicity. - Corticosteroids: combined use raises the chance of tendon rupture. - Cyclosporine: may increase cyclosporine plasma levels.

Moderate Interactions (Monitor Closely): - NSAIDs: heightened risk of central nervous system adverse events. - Oral hypoglycemic agents: possible alteration of blood glucose control. - Oral contraceptives: reduced hormonal efficacy, consider backup contraception. - Diabetic medications: monitor for hypoglycemia or hyperglycemia. - Antidepressants (SSRIs): watch for additive QT prolongation.